Apellis Pharmaceuticals raised $47.1M Series D venture round, led by Bihua Chen.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$140.1M
Top Valuation
-
Apellis Pharmaceuticals raised $47.1M in a Series D round.
The round was announced on 02/12/16.
The round was led by Bihua Chen, Hillhouse Capital Group.